Charles Schwab’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-178,592
| Closed | -$289K | – | 3561 |
|
|
2024
Q2 | $289K | Sell |
178,592
-87,332
| -33% | -$141K | ﹤0.01% | 3375 |
|
|
2024
Q1 | $452K | Buy |
265,924
+7,397
| +3% | +$12.6K | ﹤0.01% | 3065 |
|
|
2023
Q4 | $801K | Sell |
258,527
-11,070
| -4% | -$34.3K | ﹤0.01% | 2906 |
|
|
2023
Q3 | $1.66M | Buy |
269,597
+9,755
| +4% | +$59.9K | ﹤0.01% | 2657 |
|
|
2023
Q2 | $1.63M | Buy |
259,842
+6,368
| +3% | +$39.9K | ﹤0.01% | 2615 |
|
|
2023
Q1 | $1.21M | Buy |
253,474
+1,515
| +0.6% | +$7.23K | ﹤0.01% | 2677 |
|
|
2022
Q4 | $2.19M | Buy |
251,959
+3,483
| +1% | +$30.3K | ﹤0.01% | 2541 |
|
|
2022
Q3 | $2.96M | Buy |
248,476
+35,579
| +17% | +$423K | ﹤0.01% | 2465 |
|
|
2022
Q2 | $3.03M | Buy |
212,897
+18,021
| +9% | +$257K | ﹤0.01% | 2409 |
|
|
2022
Q1 | $4.06M | Buy |
194,876
+5,097
| +3% | +$106K | ﹤0.01% | 2376 |
|
|
2021
Q4 | $4.38M | Buy |
189,779
+2,616
| +1% | +$60.4K | ﹤0.01% | 2410 |
|
|
2021
Q3 | $5.58M | Buy |
187,163
+72,875
| +64% | +$2.17M | ﹤0.01% | 2322 |
|
|
2021
Q2 | $3.91M | Buy |
114,288
+29,203
| +34% | +$998K | ﹤0.01% | 2466 |
|
|
2021
Q1 | $2.8M | Buy |
85,085
+1,921
| +2% | +$63.2K | ﹤0.01% | 2551 |
|
|
2020
Q4 | $5.12M | Buy |
+83,164
| New | +$5.12M | ﹤0.01% | 2198 |
|